91 related articles for article (PubMed ID: 44694)
41. [The effect of taftsin on the function of the brain structures in rats with a dysfunctioning dopamine system].
Popova NS; Dovedova EL
Fiziol Zh Im I M Sechenova; 1995 Mar; 81(3):29-34. PubMed ID: 7581556
[TBL] [Abstract][Full Text] [Related]
42. Evidence for dopamine receptors in the human brain mediating sedation and sleep.
Corsini GU; Del Zompo M; Manconi S; Piccardi MP; Onali PL; Mangoni A
Life Sci; 1977 May; 20(9):1613-8. PubMed ID: 875637
[No Abstract] [Full Text] [Related]
43. Decrease in serum prolactin by naloxone: evidence against antidopamine and antipsychotic effects.
Gold MS; Pottash AL; Extein I; Redmond DE; Kleber HD
Am J Psychiatry; 1979 Oct; 136(10):1339-40. PubMed ID: 114063
[No Abstract] [Full Text] [Related]
44. Multiple dopamine receptors. Proceedings of a workshop at the Ninth Society for Neuroscience Annual Meeting, Atlanta, Georgia, November 1979.
Commun Psychopharmacol; 1979; 3(6):383-470. PubMed ID: 44692
[No Abstract] [Full Text] [Related]
45. Differential development of therapeutic drugs for psychosis.
Lewander T
Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():654A-655A. PubMed ID: 1354072
[No Abstract] [Full Text] [Related]
46. Approaches for finding new types of antipsychotic compounds.
Sedvall G
Acta Psychiatr Scand Suppl; 1989; 352():16-23. PubMed ID: 2573237
[TBL] [Abstract][Full Text] [Related]
47. How antipsychotics work-from receptors to reality.
Kapur S; Agid O; Mizrahi R; Li M
NeuroRx; 2006 Jan; 3(1):10-21. PubMed ID: 16490410
[TBL] [Abstract][Full Text] [Related]
48. [Neuroplegics and neuroleptics. Antipsychotics. VI. Butyrophenones (Part I)].
Deligné P; Bunodière M
Ann Anesthesiol Fr; 1979; 20(2):147-59. PubMed ID: 38710
[No Abstract] [Full Text] [Related]
49. Purification and properties of brain neuroleptic-binding proteins.
Sartania NA; Abutidze KD; Mikeladze DG
J Protein Chem; 1989 Jun; 8(3):339-40. PubMed ID: 2571344
[No Abstract] [Full Text] [Related]
50. The effect of 2-substitution on conformations and brain concentrations of phenothiazine-neuroleptics in relation to dopamine-antagonism.
Grol CJ; Rollema H; Asselbergs HW
J Pharm Pharmacol; 1979 Oct; 31(10):667-71. PubMed ID: 41038
[No Abstract] [Full Text] [Related]
51. [Dopaminergic receptors in the brain].
Alexandrová M
Cesk Fysiol; 1984; 33(3):227-40. PubMed ID: 6147203
[No Abstract] [Full Text] [Related]
52. The interaction of chlorpromazine and butyrophenones with glutamate dehydrogenase.
Tamir A; Rigbi M; Levitzki A
Biochem Pharmacol; 1981 Jun; 30(12):1469-73. PubMed ID: 6115645
[No Abstract] [Full Text] [Related]
53. The clinical position of moperone among the butyrophenones.
Gross H; Kaltenbäck E
Nord Psykiatr Tidsskr; 1969; 23(1):4-9. PubMed ID: 5354545
[No Abstract] [Full Text] [Related]
54. Bromerguride--an ergoline derivative with atypical neuroleptic properties.
Löschmann PA; Horowski R; Wachtel H
Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():263A-264A. PubMed ID: 1354031
[No Abstract] [Full Text] [Related]
55. Symposium on: receptors of dopamine antagonists: new biochemical approaches. July 6-8, 1978, Beerse, Belgium.
Life Sci; 1978 Aug; 23(6):537-658. PubMed ID: 29193
[No Abstract] [Full Text] [Related]
56. Symposium on: receptors of dopamine antagonists: new biochemical approaches. July 6--8, 1978, Beerse, Belgium.
Life Sci; 1978 Aug; 23(5):419-536. PubMed ID: 29183
[No Abstract] [Full Text] [Related]
57. Haloperidol-desipramine interaction in mice, rats and man.
Morselli PL; Rizzo M; Zaccala M; Garattini S
Chem Biol Interact; 1970 Aug; 2(2):160-4. PubMed ID: 5526730
[No Abstract] [Full Text] [Related]
58. Dopamine receptors and average clinical doses.
Meltzer HY
Science; 1976 Oct; 194(4264):545-6. PubMed ID: 9693
[No Abstract] [Full Text] [Related]
59. [Dopaminergic receptors in the gastrointestinal tract].
Kurtz W
Klin Wochenschr; 1988 Mar; 66(5):225-6. PubMed ID: 3361799
[No Abstract] [Full Text] [Related]
60. A comparison between the conformation of dexclamol and the tricyclic and butyrophenone type dopamine antagonists.
Moereels H; Tollenaere JP
Life Sci; 1978 Aug; 23(5):459-63. PubMed ID: 29188
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
